Pain Sensitivity Assessment During Puberty for Pain
Trial Summary
What is the purpose of this trial?
Aim 1- To examine the differences in pain sensitivity between adolescents at early vs. mid pubertal status Aim 2- To determine the relationships between sex hormone levels and pain sensitivity Exploratory Aim 1- To determine the effect of pubertal maturation on pain sensitivity Exploratory Aim 2- To identify parameters related to who will develop chronic pain during puberty Hypothesis 1- Adolescents in early pubertal status will have higher pain ratings and lower pain modulation capabilities compared to adolescents in mid puberal status. Hypothesis 2- Pain sensitivity will be associated with sex hormone levels. Exploratory Hypothesis 1- As adolescents mature, they will have a decrease in pain sensitivity to experimental pain which will be related to changes in sex hormone levels. Exploratory hypothesis 2- Female adolescents with greater pain sensitivity, lower testosterone levels and with a family history of pain would be at a higher risk to develop chronic pain
Research Team
Hadas Nahman-Averbuch, PhD
Principal Investigator
Washington University School of Medicine
Eligibility Criteria
This trial is for healthy boys and girls aged 9-16 who speak English. It's not for those who are pregnant, have chronic pain or frequent headaches, psychiatric or neurological issues, sensation loss in limbs to be tested, conditions affecting puberty, or take regular pain meds.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Cold pain tolerance (Behavioral Intervention)
- Conditioned pain modulation (CPM) efficiency (Behavioral Intervention)
- Mechanical Stimuli (Device)
- Mechanical temporal summation (Behavioral Intervention)
- Offset analgesia efficiency (Behavioral Intervention)
- Pain Ratings (Behavioral Intervention)
- Pressure pain thresholds (PPT) (Behavioral Intervention)
- Pressure Stimuli (Device)
- Thermal pain thresholds (Behavioral Intervention)
- Thermal Sensory Analyzer (Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
David H. Perlmutter
Washington University School of Medicine
Chief Executive Officer since 2015
MD from Washington University School of Medicine
Paul Scheel
Washington University School of Medicine
Chief Medical Officer since 2022
MD from Washington University School of Medicine